Cargando…

Injection Molded Autoclavable, Scalable, Conformable (iMASC) system for aerosol-based protection: a prospective single-arm feasibility study

OBJECTIVE: To develop and test a new reusable, sterilisable N95 filtering facepiece respirator (FFR)-comparable face mask, known as the Injection Molded Autoclavable, Scalable, Conformable (iMASC) system, given the dire need for personal protective equipment within healthcare settings during the COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Byrne, James D, Wentworth, Adam J, Chai, Peter R, Huang, Hen-Wei, Babaee, Sahab, Li, Canchen, Becker, Sarah L, Tov, Caitlynn, Min, Seokkee, Traverso, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342850/
https://www.ncbi.nlm.nih.gov/pubmed/32641368
http://dx.doi.org/10.1136/bmjopen-2020-039120
_version_ 1783555607929815040
author Byrne, James D
Wentworth, Adam J
Chai, Peter R
Huang, Hen-Wei
Babaee, Sahab
Li, Canchen
Becker, Sarah L
Tov, Caitlynn
Min, Seokkee
Traverso, Giovanni
author_facet Byrne, James D
Wentworth, Adam J
Chai, Peter R
Huang, Hen-Wei
Babaee, Sahab
Li, Canchen
Becker, Sarah L
Tov, Caitlynn
Min, Seokkee
Traverso, Giovanni
author_sort Byrne, James D
collection PubMed
description OBJECTIVE: To develop and test a new reusable, sterilisable N95 filtering facepiece respirator (FFR)-comparable face mask, known as the Injection Molded Autoclavable, Scalable, Conformable (iMASC) system, given the dire need for personal protective equipment within healthcare settings during the COVID-19 pandemic. DESIGN: Single-arm feasibility study. SETTING: Emergency department and outpatient oncology clinic. PARTICIPANTS: Healthcare workers who have previously undergone N95 fit testing. INTERVENTIONS: Fit testing of new iMASC system. PRIMARY AND SECONDARY OUTCOME MEASURES: Primary outcome is success of fit testing using an Occupational Safety and Health Administration (OSHA)-approved testing method, and secondary outcomes are user experience with fit, breathability and filter replacement. RESULTS: Twenty-four subjects were recruited to undergo fit testing, and the average age of subjects was 41 years (range of 21–65 years) with an average body mass index of 26.5 kg/m(2). The breakdown of participants by profession was 46% nurses (n=11), 21% attending physicians (n=5), 21% resident physicians (n=5) and 12% technicians (n=3). Of these participants, four did not perform the fit testing due to the inability to detect saccharin solution on premask placement sensitivity test, lack of time and inability to place mask over hair. All participants (n=20) who performed the fit test were successfully fitted for the iMASC system using an OSHA-approved testing method. User experience with the iMASC system, as evaluated using a Likert scale with a score of 1 indicating excellent and a score of 5 indicating very poor, demonstrated an average fit score of 1.75, breathability of 1.6, and ease of replacing the filter on the mask was scored on average as 2.05. CONCLUSIONS: The iMASC system was shown to successfully fit multiple different face sizes and shapes using an OSHA-approved testing method. These data support further certification testing needed for use in the healthcare setting.
format Online
Article
Text
id pubmed-7342850
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-73428502020-07-09 Injection Molded Autoclavable, Scalable, Conformable (iMASC) system for aerosol-based protection: a prospective single-arm feasibility study Byrne, James D Wentworth, Adam J Chai, Peter R Huang, Hen-Wei Babaee, Sahab Li, Canchen Becker, Sarah L Tov, Caitlynn Min, Seokkee Traverso, Giovanni BMJ Open Global Health OBJECTIVE: To develop and test a new reusable, sterilisable N95 filtering facepiece respirator (FFR)-comparable face mask, known as the Injection Molded Autoclavable, Scalable, Conformable (iMASC) system, given the dire need for personal protective equipment within healthcare settings during the COVID-19 pandemic. DESIGN: Single-arm feasibility study. SETTING: Emergency department and outpatient oncology clinic. PARTICIPANTS: Healthcare workers who have previously undergone N95 fit testing. INTERVENTIONS: Fit testing of new iMASC system. PRIMARY AND SECONDARY OUTCOME MEASURES: Primary outcome is success of fit testing using an Occupational Safety and Health Administration (OSHA)-approved testing method, and secondary outcomes are user experience with fit, breathability and filter replacement. RESULTS: Twenty-four subjects were recruited to undergo fit testing, and the average age of subjects was 41 years (range of 21–65 years) with an average body mass index of 26.5 kg/m(2). The breakdown of participants by profession was 46% nurses (n=11), 21% attending physicians (n=5), 21% resident physicians (n=5) and 12% technicians (n=3). Of these participants, four did not perform the fit testing due to the inability to detect saccharin solution on premask placement sensitivity test, lack of time and inability to place mask over hair. All participants (n=20) who performed the fit test were successfully fitted for the iMASC system using an OSHA-approved testing method. User experience with the iMASC system, as evaluated using a Likert scale with a score of 1 indicating excellent and a score of 5 indicating very poor, demonstrated an average fit score of 1.75, breathability of 1.6, and ease of replacing the filter on the mask was scored on average as 2.05. CONCLUSIONS: The iMASC system was shown to successfully fit multiple different face sizes and shapes using an OSHA-approved testing method. These data support further certification testing needed for use in the healthcare setting. BMJ Publishing Group 2020-07-07 /pmc/articles/PMC7342850/ /pubmed/32641368 http://dx.doi.org/10.1136/bmjopen-2020-039120 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Global Health
Byrne, James D
Wentworth, Adam J
Chai, Peter R
Huang, Hen-Wei
Babaee, Sahab
Li, Canchen
Becker, Sarah L
Tov, Caitlynn
Min, Seokkee
Traverso, Giovanni
Injection Molded Autoclavable, Scalable, Conformable (iMASC) system for aerosol-based protection: a prospective single-arm feasibility study
title Injection Molded Autoclavable, Scalable, Conformable (iMASC) system for aerosol-based protection: a prospective single-arm feasibility study
title_full Injection Molded Autoclavable, Scalable, Conformable (iMASC) system for aerosol-based protection: a prospective single-arm feasibility study
title_fullStr Injection Molded Autoclavable, Scalable, Conformable (iMASC) system for aerosol-based protection: a prospective single-arm feasibility study
title_full_unstemmed Injection Molded Autoclavable, Scalable, Conformable (iMASC) system for aerosol-based protection: a prospective single-arm feasibility study
title_short Injection Molded Autoclavable, Scalable, Conformable (iMASC) system for aerosol-based protection: a prospective single-arm feasibility study
title_sort injection molded autoclavable, scalable, conformable (imasc) system for aerosol-based protection: a prospective single-arm feasibility study
topic Global Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342850/
https://www.ncbi.nlm.nih.gov/pubmed/32641368
http://dx.doi.org/10.1136/bmjopen-2020-039120
work_keys_str_mv AT byrnejamesd injectionmoldedautoclavablescalableconformableimascsystemforaerosolbasedprotectionaprospectivesinglearmfeasibilitystudy
AT wentworthadamj injectionmoldedautoclavablescalableconformableimascsystemforaerosolbasedprotectionaprospectivesinglearmfeasibilitystudy
AT chaipeterr injectionmoldedautoclavablescalableconformableimascsystemforaerosolbasedprotectionaprospectivesinglearmfeasibilitystudy
AT huanghenwei injectionmoldedautoclavablescalableconformableimascsystemforaerosolbasedprotectionaprospectivesinglearmfeasibilitystudy
AT babaeesahab injectionmoldedautoclavablescalableconformableimascsystemforaerosolbasedprotectionaprospectivesinglearmfeasibilitystudy
AT licanchen injectionmoldedautoclavablescalableconformableimascsystemforaerosolbasedprotectionaprospectivesinglearmfeasibilitystudy
AT beckersarahl injectionmoldedautoclavablescalableconformableimascsystemforaerosolbasedprotectionaprospectivesinglearmfeasibilitystudy
AT tovcaitlynn injectionmoldedautoclavablescalableconformableimascsystemforaerosolbasedprotectionaprospectivesinglearmfeasibilitystudy
AT minseokkee injectionmoldedautoclavablescalableconformableimascsystemforaerosolbasedprotectionaprospectivesinglearmfeasibilitystudy
AT traversogiovanni injectionmoldedautoclavablescalableconformableimascsystemforaerosolbasedprotectionaprospectivesinglearmfeasibilitystudy